By providing a concise summary of the #epidemiological and #virological situation for respiratory virus infections, #ERVISS supports #PublicHealth decision-makers to take timely, well-informed decisions to limit the impact on healthcare systems and the wider public. 
EU is experiencing a warming trend where heat waves and flooding become more frequent and severe, and summers are getting longer and warmer.
Currently authorised vaccines continue to be effective at preventing hospitalisation, severe disease and death due to #COVID19.
Mathematical modelling indicates that #XBB15 could become dominant in the EU/EEA after 1-2 months, given the current low proportions reported in the EU/EEA & its estimated growth rate.
Vaccines are continuing to prevent many millions of EU citizens from becoming very ill or dying and figures show that numbers of hospitalisations and deaths remain lowest in those Member States with the highest vaccination rates.
Providing all eligible individuals with the recommended dose regimen should remain the current
2. They should be considered only as a 𝗖𝗢𝗠𝗣𝗟𝗘𝗠𝗘𝗡𝗧𝗔𝗥𝗬 measure, not as a replacement for #PhysicalDistancing, cough and sneeze etiquette, #HandHygiene & avoiding touching of one's face. 
@ppenttin @Eurosurveillanc @WHO @WHO_Europe @EU_Commission @Europarl_EN @EUCouncilPress @POLITICOEurope @euronews @EU_Health #nCoV2019 Questions & Answers:
